Dr. Caiola received his PhD in mathematics from Rensselaer Polytechnic Institute in 2016 during which he modeled the onset and progression of Parkinson’s Disease. He then worked in Dr. Thomas Wichmann’s lab at Emory University as a Postdoctoral Fellow where he investigated changes in the basal ganglia and thalamus using a primate model of parkinsonism and in vivo electrophysiologic and optogenetic techniques. In addition to the Neuropharmacology and Neurologic Diseases Department, Dr. Caiola was also affiliated with the Emory Department of Mathematics where he taught life science calculus as a Visiting Assistant Professor. He joined the US Food and Drug Administration’s Office of Science and Engineering Laboratories in the Center for Devices and Radiological Health in 2020 where he performs regulatory science in the field of neurological devices.


  • Ph.D.
    Rensselaer Polytechnic Institute
  • M.S.
    Rensselaer Polytechnic Institute
  • B.A.
    Marist College

My medical device research focuses on projects the evaluate the safety and efficacy of diagnostic and therapeutic neurological devices. My lab is currently focusing on neurological diseases such as Traumatic Brain Injury and Parkinson’s Disease and is interested in identifying diagnostic and therapeutic biomarkers for neurological disease using ML/AI techniques, virtual reality, wearable devices, and human studies.

Research Methods
Human Studies
Mathematical modeling
Research Interests
Parkinson's Disease
Traumatic Brain Injury
Mental Health
Virtual Reality
Wearable Devices

Current Students

Former Students

Dr. Michael Caiola photo
Office of Science and Engineering Laboratories, U.S. Food and Drug Administration
Neuroscience and Cognitive Science
michael.caiola [at] fda.hhs.gov